Cytosorbents Crp (CTSO) — Cash Flow Quality Index
Latest as of June 2025:
-0.78x
Cytosorbents Crp (CTSO) has a Cash Flow Quality Index of -0.78x as of June 2025. Operating cash flow of $-1.51 Million is below net income of $1.95 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Cytosorbents Crp strategic investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
-0.78x
Operating CF / Net Income
Operating Cash Flow
$-1.51 Million
USD
Net Income
$1.95 Million
USD
Data as of
Jun 2025
Most recent filing
Annual Cash Flow Quality Index for Cytosorbents Crp (None–None)
Year-by-year earnings quality comparison for Cytosorbents Crp. For live market cap and the full company financial profile, see market cap of Cytosorbents Crp.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.